non glp 1 weight loss medication GLP-1 Companion Health Pack Daily Packets My Insurance Won't Cover GLP-1

Psychological symptoms in COVID-19 patients: insights into pathophysiology and risk factors of long COVID-19

We also look into how these choices are backed by science and where the evidence gap exists

Z.ParmarR

Al-Aly explained that the use of GLP-1s has soared in the last couple years while multiple studies have captured their far-reaching benefits, but [we] realized that no one has comprehensively investigated the effectiveness and risks of GLP-1 receptor agonists across all possible health outcomes. In the study, Al-Aly and colleagues mapped out associations between GLP-1s and 175 possible health outcomes by comparing a cohort of people with diabetes who used the treatments (n = 215,970) with: those who used sulfonylureas (n = 159,465)

Xie A, Hanif S, Ouyang J, Tang Z, Kong N, Kim NY, et al